Rafarm

Rafarm is a fully integrated pharmaceutical company established in 1970 in Greece, specializing in ophthalmic and complex injectable products. The company operates under business principles that prioritize high-quality medicines at affordable prices. Its core mission involves putting these beliefs into practice through rigorous development and production processes. Rafarm's strategic focus on specialized pharmaceutical segments positions it as a key player in its niche markets.

With an employee range of 500 - 1,000 individuals, Rafarm continuously invests in advanced technology and implements the strictest quality standards across all phases of product development and manufacturing. This commitment ensures the integrity and efficacy of its specialized pharmaceutical offerings. The company's operational excellence is supported by a dedicated team focused on innovation and adherence to global regulatory requirements. Meet Rafarm's team to understand the expertise driving their specialized production.

Rafarm has cultivated partnerships with leading companies across Europe and extends its reach to over 60 countries worldwide, including significant markets like the U.S., Canada, and Australia. A substantial investment program is currently underway, designed to expand its capabilities and enable the production of medicines with highly advanced technological specifications. This forward-looking strategy underscores Rafarm's dedication to growth and its ambition to remain at the forefront of pharmaceutical innovation.